KMB vs UNICY: Which Is the Better Buy in 2026?
Last updated October 2026
Short answer
KMB is the larger of the two ($31.23B market cap): the incumbent the market prices for continued execution (12.60x forward earnings, beta 0.27). UNICY is the smaller challenger ($10.50B): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
KMB vs UNICY: the tie-breaker metrics
Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | KMB | UNICY | What it tells you |
|---|---|---|---|
| Market cap | $31.23B | $10.50B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Trailing P/E | 18.59 | 25.42 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 0.27 | 0.28 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 5% of range | 42% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 17.88 | 2.04 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Before you buy: how KMB and UNICY affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. KMB and UNICY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined KMB and UNICY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Kimberly-Clark (KMB) do?
Kimberly-Clark is a consumer staples company that makes and sells personal care and tissue products under household brand names. Its portfolio includes Huggies diapers, Pull-Ups training pants, Kotex feminine care, Depend and Poise adult incontinence products, Kleenex tissues, Cottonelle and Scott bath tissue, and Viva paper towels. The company organizes around three segments: Personal Care (its largest and most profitable), Consumer Tissue, and a professional/away-from-home business serving offices, restaurants, and institutions (sold under the Kimberly-Clark Professional banner). Roughly half of revenue comes from outside North America, with meaningful exposure to developing and emerging markets where category penetration is still rising. Kimberly-Clark makes money by selling repeat-purchase, non-discretionary household essentials at scale, leaning on brand strength, retail distribution, and manufacturing efficiency. The business is a classic defensive staple: steady demand, modest organic growth, and a long dividend history. Headquartered in Irving, Texas, it has been a Dividend Aristocrat for decades.
What does Unicharm Corporation (UNICY) do?
Unicharm Corporation makes disposable hygiene products and pet supplies, reporting in yen under IFRS on a January to December year. Personal Care (wellness care for older adults, feminine care and baby care) produced ¥774.4 billion of fiscal 2025's ¥945.3 billion in sales (about 82%) and ¥83.2 billion of its ¥108.9 billion core operating income. Pet Care (dog and cat food, treats and pet toiletries) added ¥156.1 billion of sales (about 17%) and ¥24.1 billion of core operating income, a higher margin than the core business. Industrial nonwovens make up the small remainder. Brands include Moony and MamyPoko diapers, Sofy pads, Lifree incontinence products, and Gran Deli, Silver Spoon and Deo-clean in pet care. By selling subsidiary, 2025 sales were ¥342.5 billion in Japan (about 36%), ¥78.0 billion in China, ¥311.3 billion in the rest of Asia and ¥213.5 billion elsewhere, mainly North America, the Middle East and Oceania.
KMB vs UNICY: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- KMB drivers: Defensive, repeat-purchase demand; Emerging-market category growth.
- UNICY drivers: Wellness care and an aging Asia; Pet care as a growth and margin engine.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Kimberly-Clark sells largely commoditized products where private-label store brands compete aggressively on price, capping pricing power and pressuring volumes when consumers trade down. For UNICY, the nearest risk is input and freight costs.
KMB or UNICY: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick KMB if you believe its drivers more; UNICY if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the KMB and UNICY guides.
KMB vs UNICY: the full fundamentals
KMB. Kimberly-Clark trades at a defensive-staples multiple, lower than faster-growing consumer names but supported by a high, durable dividend yield. The valuation reflects slow organic growth offset by predictable cash flow and decades of dividend increases. It tends to be valued like a bond proxy, with the multiple sensitive to interest rates and the dividend yield as the primary anchor for income investors.
UNICY. The trailing figures combine fiscal 2025 with the first half of 2026 and show a business clawing back from a weak year. Core operating income of ~¥117 billion is above 2025's ¥108.9 billion but well short of 2024's ¥138.5 billion. The revised full-year guidance points to a softer second half, so the recovery is not yet a straight line. Profit attributable to owners dipped 1.9% in the first half despite higher operating profit, because 2025 included ¥5.3 billion of fire insurance proceeds from India. The balance sheet is close to debt-free, which is why the company can promise a 65% total return ratio while still buying businesses.
Headline figures (approximate, early 2026): KMB shows revenue (ttm) ~$20 billion, operating margin ~16%, net income (ttm) ~$2.5 billion, p/e (ttm) ~18x; UNICY shows net sales (ttm to june 2026) ~¥968 billion, core operating income (ttm) ~¥117 billion, profit to owners (ttm) ~¥64 billion, fy2026 guidance (aug 2026) ¥1,015B sales, ¥113B core OI, EPS ¥40.68.
The bottom line: KMB vs UNICY
KMB and UNICY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined KMB and UNICY exposure against your real portfolio. It is not an investment adviser.
Wondering how KMB or UNICY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Investing in Kimberly-Clark with AI
Connect the broker you already use and ask Walnut's AI how KMB fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
What is the difference between KMB and UNICY?
+
Kimberly-Clark is a consumer staples company that makes and sells personal care and tissue products under household brand names. Unicharm Corporation makes disposable hygiene products and pet supplies, reporting in yen under IFRS on a January to December year. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is KMB or UNICY the better stock?
+
Neither is universally better. KMB is the larger incumbent; UNICY is the smaller challenger. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, KMB or UNICY?
+
A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both KMB and UNICY?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of KMB vs UNICY?
+
KMB: Kimberly-Clark sells largely commoditized products where private-label store brands compete aggressively on price, capping pricing power and pressuring volumes when consumers trade down. Input costs (pulp, resin, energy) and currency swings hit margins directly given heavy emerging-market exposure. Organic growth is structurally slow, so the stock behaves like a bond proxy and can lag in risk-on markets and underperform when interest rates rise. Major customers like Walmart hold negotiating leverage, and birth-rate declines in developed markets pressure the diaper category over time. UNICY: The nearest risk is input and freight costs. Unicharm cut its 2026 core operating income forecast by 16.9% in August because it expects sharp rises in raw material and logistics costs from the Middle East conflict, and the implied second half is weaker than a year earlier even after a strong first half. China is the second risk. Sales there fell about 27% in 2025, management blames repeated reputational damage, and the payoff from its upfront investment in e-commerce, wellness and pet care had not shown up as of June 2026. Currency moves both ways for a yen reporter: first-half 2026 sales in Asia rose 3.4% in yen but fell 2.5% in local currency terms, so a stronger yen would take away part of the reported growth. Japan's baby care market keeps shrinking with the birth rate, which pushes the company to rely on adult care, pet care and price increases at home. Competition is heavy in every category, and cheaper local brands gain share when consumers trade down, as the company says is happening in Asian baby care. The 2030 targets (¥1.3 trillion of sales, a 15% core margin, 15% ROE) are well above 2025's 11.5% margin and 8.3% ROE, and the previous plan's 2026 goal of ¥1.15 trillion in sales was not reached. For ADR holders, the founding family's roughly 30% combined stake limits outside influence, and Japanese tax is withheld from dividends.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell KMB or UNICY; figures are approximate and dated (as of October 2026). Verify current data before investing.